Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
![](../../images/overlap_matrix_icon.png)
11
Number of overlapping holdings
17.7%
% of XLV's 62 holdings also in PPH
45.8%
% of PPH's 27 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in PPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 12.0% | 12.4% | 12.0% | |
JOHNSON & JOHNSON | 6.8% | 6.4% | 6.4% | |
ABBVIE INC | 5.9% | 5.9% | 5.9% | |
MERCK & CO. INC. | 5.0% | 5.0% | 5.0% | |
PFIZER INC | 2.8% | 4.3% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to PPH
UNITEDHEALTH GROUP INC | 9.3% | |
THERMO FISHER SCIENTIFIC INC | 3.9% | |
ABBOTT LABORATORIES | 3.8% | |
INTUITIVE SURGICAL INC | 3.7% | |
DANAHER CORP | 2.9% | |
AMGEN INC | 2.8% | |
BOSTON SCIENTIFIC CORP | 2.6% | |
STRYKER CORP | 2.5% | |
VERTEX PHARMACEUTICALS INC | 2.3% | |
GILEAD SCIENCES INC | 2.2% |
XLV Underweight Relative to PPH
NOVO-NORDISK A/S-SPONS ADR | -8.1% | |
NOVARTIS AG-ADR | -4.7% | |
ASTRAZENECA PLC-SPONS ADR | -4.6% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.5% | |
MCKESSON CORP | -4.2% | |
AMERISOURCEBERGEN CORP | -4.1% | |
SANOFI-AVENTIS-ADR | -4.0% | |
GLAXOSMITHKLINE PLC-SPON ADR | -3.9% | |
TEVA PHARMACEUTICAL-SP ADR | -3.6% | |
BRISTOL-MYERS SQUIBB CO | -3.5% |